Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03689738 · ClinicalTrials.gov registry record · NA
Effects of Potato Resistant Starch Intake on Insulin Sensitivity, Related Metabolic Markers and Satiety
A NA study of Insulin Sensitivity and Lipid Metabolism, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT03689738: Completed NA study of Insulin Sensitivity and Lipid Metabolism, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
NCT03689738 is a NA study of Insulin Sensitivity and Lipid Metabolism that has completed, run by Midwest Center for Metabolic and Cardiovascular Research. The registered enrollment target is 24 participants, below the 72-participant average among 29 other Insulin Sensitivity trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03689738, a NA study of Insulin Sensitivity and Lipid Metabolism, has completed, sponsored by Midwest Center for Metabolic and Cardiovascular Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to assess whether intake of baked and then chilled potatoes over a 24-h period, compared to intake of isocaloric, carbohydrate (CHO)-matched foods low in fiber and resistant starch (RS), will increase insulin sensitivity, breath hydrogen and satiety, and decrease hunger and free fatty acid (FFA) levels in overweight or obese men and women at risk for metabolic syndrome and diabetes mellitus.
Primary Outcome
Difference in the Matsuda insulin sensitivity index (MISI) between the Potato and Control conditions following a breakfast meal tolerance test (MTT) completed on day 2 of each treatment period.
Conditions Studied
Interventions
- OTHER Potato (Resistant Starch)
- OTHER CHO-matched (Low-fiber, RS-free)
Study Locations (1)
Florida
- Cathy Maki - Boca Raton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-09-24 |
| Est. Completion | 2019-02-20 |
| Phase | NA |
What the finished NCT03689738 record still lists
NCT03689738 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 72-participant average among 29 other Insulin Sensitivity trials with a reported enrollment target (67% lower).
The record links to 4 conditions, with Insulin Sensitivity appearing as the primary indexed condition, and to 2 interventions - of which Potato (Resistant Starch) is the first listed.
NCT03689738 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03689738 about?
NCT03689738 is a clinical study titled "Effects of Potato Resistant Starch Intake on Insulin Sensitivity, Related Metabolic Markers and Satiety". The objective of this study is to assess whether intake of baked and then chilled potatoes over a 24-h period, compared to intake of isocaloric, carbohydrate (CHO)-matched foods low in fiber and resistant starch (RS), will increase insulin sensitivity, breath hydrogen and satiety, and decrease hunge...
What is the current status of trial NCT03689738?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2018-09-24. Estimated completion is 2019-02-20.
What conditions does trial NCT03689738 study?
This clinical trial studies the following conditions: Insulin Sensitivity, Lipid Metabolism, Resistant Starch, Potato.
What interventions are being tested in trial NCT03689738?
The interventions under investigation include: Potato (Resistant Starch) (OTHER), CHO-matched (Low-fiber, RS-free) (OTHER).
Who is sponsoring clinical trial NCT03689738?
This trial is sponsored by Midwest Center for Metabolic and Cardiovascular Research, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03689738 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Sensitivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03689738's enrollment target sits among peer trials
24 22nd of 29 higher than 8 of 29 other Insulin Sensitivity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insulin Sensitivity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Countermeasures to Circadian Misalignment
RECRUITING · NA
-
Effect of Pulsatile Hormone Administration on Insulin Action
RECRUITING · NA
-
Mechanisms of Ultrasound Neuromodulation Effects in Diabetes
RECRUITING · NA
-
Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI